Generate a tailored SOP for Dr. Daniel Powell. Improve your application with a focused, well-structured draft.
Daniel J. Powell Jr., Ph.D. is a professor in the Department of Pathology Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania. His research focuses on immune-based therapies for cancer, particularly gynecologic cancers. At the helm of the Powell Lab, he investigates the generation and isolation of high avidity, tumor-reactive T cells from heterogeneous tumor-infiltrating lymphocyte populations. His work emphasizes the unique properties of cancer cells traditionally deemed 'non-immunogenic' and explores novel T cell capture techniques that enable the characterization of immune cell functions. The lab is pioneering new tumor model systems aimed at optimizing immunotherapy strategies, such as bispecific antibodies and checkpoint inhibitors, as well as utilizing genetic engineering methods to create tumor-reactive T cells. With a commitment to translating laboratory findings into clinical applications, Powell's ongoing work includes the development of CAR T cell therapies and refining approaches to enhance endogenous antitumor responses. He leads numerous clinical trials aimed at validating these innovative strategies.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.